Masami Morimatsu Selected Research

BRCA2 Protein

4/2022	BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents.
10/2005	Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masami Morimatsu Research Topics

Disease

11	Neoplasms (Cancer) 06/2017 - 10/2003
5	Breast Neoplasms (Breast Cancer) 04/2022 - 10/2003
4	Infections 07/2017 - 10/2007
3	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 11/2015
3	Virus Diseases (Viral Diseases) 01/2018 - 01/2016
3	Flavivirus Infections 01/2018 - 11/2016
2	Glioma (Gliomas) 12/2020 - 03/2018
2	Microphthalmos 01/2009 - 04/2008
2	Inflammation (Inflammations) 12/2005 - 11/2004
1	Hemangiosarcoma (Angiosarcoma) 04/2022
1	Starvation 01/2021
1	Chondrosarcoma 12/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020
1	Influenza in Birds (Avian Flu) 01/2016
1	Depressive Disorder (Melancholia) 05/2015
1	Hypersensitivity (Allergy) 09/2014
1	Ataxia (Dyssynergia) 08/2010
1	Pseudorabies 10/2007
1	Carcinogenesis 10/2005
1	Atopic Dermatitis (Atopic Eczema) 12/2004
1	Mastitis 04/2004
1	Neoplasm Metastasis (Metastasis) 10/2003

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2004
6	Antiviral Agents (Antivirals)IBA 07/2017 - 10/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 10/2008
4	AndrogensIBA 06/2021 - 11/2015
4	NectinsIBA 07/2017 - 10/2007
3	Ligases (Synthetase)IBA 01/2018 - 11/2016
3	Immunoglobulin G (IgG)IBA 07/2017 - 04/2008
3	Messenger RNA (mRNA)IBA 07/2015 - 04/2004
2	BRCA2 ProteinIBA 04/2022 - 10/2005
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2020 - 03/2018
2	Androgen Receptors (Androgen Receptor)IBA 06/2017 - 11/2015
2	2',5'-oligoadenylate (PAPAPA)IBA 01/2017 - 11/2016
1	AlpelisibIBA 04/2022
1	polyglutamineIBA 06/2021
1	5' Untranslated Regions (5' UTR)IBA 01/2021
1	InterferonsIBA 11/2016
1	Humanized Monoclonal AntibodiesIBA 01/2016
1	NucleoproteinsIBA 01/2016
1	AntibodiesIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Glutamine (L-Glutamine)FDA Link 11/2015
1	Antidepressive Agents (Antidepressants)IBA 05/2015
1	Rad51 RecombinaseIBA 01/2015
1	Immunoglobulin E (IgE)IBA 09/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2014
1	Amino Acids FDA Link 01/2012
1	Pharmaceutical PreparationsIBA 07/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2005
1	Hemoglobins (Hemoglobin)IBA 12/2005
1	Carrier Proteins (Binding Protein)IBA 12/2005
1	HaptoglobinsIBA 12/2005
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2005
1	NF-kappa B (NF-kB)IBA 11/2004
1	Chemokine ReceptorsIBA 10/2003
1	Complementary DNA (cDNA)IBA 10/2003
1	LigandsIBA 10/2003

Therapy/Procedure

2	Therapeutics 06/2021 - 11/2015
1	Drug Therapy (Chemotherapy) 04/2022
1	Immunomodulation 07/2014
1	Radiotherapy 07/2011